Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

AACR 2009: Cancer stem cells and leukaemia

Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School...

AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research

AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )

Benefits of azacitidine for treatment of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...

Benefits of azacitidine for treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )

Epigenetics of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...

Epigenetics of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )

Innovation in the treatment of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...

Innovation in the treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )

Myelodysplastic syndromes (MDS)

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...

Myelodysplastic syndromes (MDS) ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )

AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia...

Dr Charles Mullighan - Department of Pathology, St Jude Children's Research...

AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )

AACR 2009: Membrane microfilter device for capture and characterisation of...

Anthony Williams - Keck School of Medicine, University of Southern California

AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )

AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia

Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of...

AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of...

Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )

Managing cardiotoxicity while treating cancer

Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute...

Managing cardiotoxicity while treating cancer ( Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of Oncology, Milan )

Azacitidine for Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease...

Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )

More from ecancer